School of Electrical, Mechanical and Biomedical Engineering
PEOPLE
- Visiting Professor
- Biomedical Engineering Discipline
- Visiting ProfessorBiomedical Engineering Discipline
Professor Besim Ben-Nissan has higher degrees in Metallurgical Engineering (ITU), Ceranic Engineering (University of New South Wales) and a Ph.D. in Mechanical and Industrial Engineering/Biomedical Engineering (University of New South Wales).
Over the last three decades together with a large numbers of PhD students he has worked on production and analysis of various biomedical implants, hydroxyapatite ceramics, advanced ceramics (alumina, zirconia, silicon nitrides), sol-gel developed nanocoatings for enhanced bioactivity, corrosion and abrasion protections, optical and electronic ceramics. He also has contributed in the areas of mechanical ¬properties of sol-gel developed nanocoatings.
In the biomedical field, he has involved with the development of materials for slow drug delivery, marine material conversion, implant technology (bioactive materials including conversion of Australian corals to hydroxyapatite bone grafts),
biomimetics (learning from nature and its application to regenerative medicine), bio-composites, investigative research on biomechanics and Finite Element Analysis (jaw bone, knee, hip joints, hip resurfacing), reliability and implant design (modular ceramic knee prosthesis, femoral head stresses). He has initiated worlds first reliable ceramic knee and hydroxyapatite sol gel derived nanocoatings.
Since 1990 he has published over 200 papers in journals, books and book chapters. He is one of the editors of the Journal of the Australian Ceramic Society and editorial board member of three international biomaterials journals. He has served as the Federal President and council member of Australian Ceramic Society (ACS), and International Society of Ceramics for Medicine and a board member of the Federation of the Advancement of Research in Medicine (FARM). He was awarded in 2000 "The Australasian Ceramic Society Award" for his contribution to Ceramic Education and Research and Development in Australia. He also received "Future Materials Award" in 2006 for his contribution to the biomedical materials field with Nanocoated materials and bone grafts. He has collaborated with a number of international groups in Japan, USA, Thailand, Finland, Israel and Turkey and held grants from the Australian Academy of Science andthe Japan Society for Promotion of Science for collaborative work in the biomedical field in USA and Japan respectively.
After serving as an academic for over 33 years he has retired "or transformed to a better state", however still contributes to science by supervising higher degree students, research and as a director of a new biomedical company "BioTomo".Professor Besim Ben-Nissan has higher degrees in Metallurgical Engineering (ITU), Ceranic Engineering (University of New South Wales) and a Ph.D. in Mechanical and Industrial Engineering/Biomedical Engineering (University of New South Wales).
Over the last three decades together with a large numbers of PhD students he has worked on production and analysis of various biomedical implants, hydroxyapatite ceramics, advanced ceramics (alumina, zirconia, silicon nitrides), sol-gel developed nanocoatings for enhanced bioactivity, corrosion and abrasion protections, optical and electronic ceramics. He also has contributed in the areas of mechanical ¬properties of sol-gel developed nanocoatings.
In the biomedical field, he has involved with the development of materials for slow drug delivery, marine material conversion, implant technology (bioactive materials including conversion of Australian corals to hydroxyapatite bone grafts),
biomimetics (learning from nature and its application to regenerative medicine), bio-composites, investigative research on biomechanics and Finite Element Analysis (jaw bone, knee, hip joints, hip resurfacing), reliability and implant design (modular ceramic knee prosthesis, femoral head stresses). He has initiated worlds first reliable ceramic knee and hydroxyapatite sol gel derived nanocoatings.
Since 1990 he has published over 200 papers in journals, books and book chapters. He is one of the editors of the Journal of the Australian Ceramic Society and editorial board member of three international biomaterials journals. He has served as the Federal President and council member of Australian Ceramic Society (ACS), and International Society of Ceramics for Medicine and a board member of the Federation of the Advancement of Research in Medicine (FARM). He was awarded in 2000 "The Australasian Ceramic Society Award" for his contribution to Ceramic Education and Research and Development in Australia. He also received "Future Materials Award" in 2006 for his contribution to the biomedical materials field with Nanocoated materials and bone grafts. He has collaborated with a number of international groups in Japan, USA, Thailand, Finland, Israel and Turkey and held grants from the Australian Academy of Science andthe Japan Society for Promotion of Science for collaborative work in the biomedical field in USA and Japan respectively.
After serving as an academic for over 33 years he has retired "or transformed to a better state", however still contributes to science by supervising higher degree students, research and as a director of a new biomedical company "BioTomo".- Academic
- Masters Research or PhD student supervision
Disciplines- Inorganic chemistry
- Materials engineering
- Associate Professor
- Biomedical Engineering Discipline
- Associate ProfessorBiomedical Engineering Discipline
Cancer biology expert who specialises in single-cell technologies for childhood cancer neuroblastoma.Cancer biology expert who specialises in single-cell technologies for childhood cancer neuroblastoma.- Academic
Disciplines- Oncology and carcinogenesis
- Lecturer
- Biomedical Engineering Discipline
- LecturerBiomedical Engineering Discipline
Dr Chaohao Chen is currently an ARC DECRA and Chancellor's Research Fellow at UTS, where he is working on advancing research in nanophotonics and computational imaging. His work focuses on developing novel optical nonlinear nanomaterials and their applications in super-resolution imaging, mid-infrared sensing, and advanced biophotonics technologies.
Dr Chen has secured 6 grants (sole/lead/2nd CI) from ARC, Australian Academy of Science, UTS and ANU, with a total research funding over 1.8 million AUD. This including ARC DECRA (Sole CI, DE250100406), ARC Discovery Project (2nd CI, DP260104454), UTS Chancellor’s Research Fellow (success rate <5%, Sole CI), Australian Academy of Science France and Europe EMCR Mobility Grants (Sole CI), and ANU ECR grant (Sole CI).
Dr Chen has published over 50 peer-reviewed articles, including eight as first/corresponding author, one book chapter, three News & Views articles (Nature Photonics 2022, Light: Science & Applications 2023, Advanced Photonics 2019), six conference proceedings, and hold seven patents. Eighty-eight percent of his publications are in the top 5% of journals by CiteScore, with over 90% in Q1 journals (Web of Science). The average impact factor of his work exceeds 15. Notably, 12 of his publications were featured as journal cover articles.
Dr Chen's contributions have significantly advanced the dynamic fields of nanophotonics and nanotechnology, particularly in computational imaging.
1) Pioneered the world's first single-beam near-infrared super-resolution imaging (1st author, Nat. Comm. 2018), resolving a major challenge in deep biological imaging caused by scattering and energy loss. This achievement delivered 50 nm resolution at a depth of 93 µm in tissues. Dr Chen further demonstrated the use of optical nonlinearity as a fingerprint for super-resolved multiplexing microscopy (co-first and co-corresponding author, Adv. Mat., 2024), advancing biomedical imaging for subcellular structures and tracking. These breakthroughs led to international patents, awards, and invitations to present at institutions like UC Berkeley.
2) Developed the Fourier domain heterochromatic fusion imaging reconstruction algorithm (1st author, Adv. Mat., 2021), achieving sub-50 nm resolution and enabling multicolour fusion for deep tissue imaging. His exploration of tunable super-linearity in nanomaterials under varying intensities (1st author, Nano Lett., 2022) expanded applications of lanthanide nanomaterials in computational imaging. He contributed as a reviewer for leading journals like Nature Photonics and Light: Science & Applications and served on the Photonics Online Meetup 2023 committee, fostering collaboration among 100 attendees and 24 organizations.
Dr Chaohao Chen is currently an ARC DECRA and Chancellor's Research Fellow at UTS, where he is working on advancing research in nanophotonics and computational imaging. His work focuses on developing novel optical nonlinear nanomaterials and their applications in super-resolution imaging, mid-infrared sensing, and advanced biophotonics technologies.
Dr Chen has secured 6 grants (sole/lead/2nd CI) from ARC, Australian Academy of Science, UTS and ANU, with a total research funding over 1.8 million AUD. This including ARC DECRA (Sole CI, DE250100406), ARC Discovery Project (2nd CI, DP260104454), UTS Chancellor’s Research Fellow (success rate <5%, Sole CI), Australian Academy of Science France and Europe EMCR Mobility Grants (Sole CI), and ANU ECR grant (Sole CI).
Dr Chen has published over 50 peer-reviewed articles, including eight as first/corresponding author, one book chapter, three News & Views articles (Nature Photonics 2022, Light: Science & Applications 2023, Advanced Photonics 2019), six conference proceedings, and hold seven patents. Eighty-eight percent of his publications are in the top 5% of journals by CiteScore, with over 90% in Q1 journals (Web of Science). The average impact factor of his work exceeds 15. Notably, 12 of his publications were featured as journal cover articles.
Dr Chen's contributions have significantly advanced the dynamic fields of nanophotonics and nanotechnology, particularly in computational imaging.
1) Pioneered the world's first single-beam near-infrared super-resolution imaging (1st author, Nat. Comm. 2018), resolving a major challenge in deep biological imaging caused by scattering and energy loss. This achievement delivered 50 nm resolution at a depth of 93 µm in tissues. Dr Chen further demonstrated the use of optical nonlinearity as a fingerprint for super-resolved multiplexing microscopy (co-first and co-corresponding author, Adv. Mat., 2024), advancing biomedical imaging for subcellular structures and tracking. These breakthroughs led to international patents, awards, and invitations to present at institutions like UC Berkeley.
2) Developed the Fourier domain heterochromatic fusion imaging reconstruction algorithm (1st author, Adv. Mat., 2021), achieving sub-50 nm resolution and enabling multicolour fusion for deep tissue imaging. His exploration of tunable super-linearity in nanomaterials under varying intensities (1st author, Nano Lett., 2022) expanded applications of lanthanide nanomaterials in computational imaging. He contributed as a reviewer for leading journals like Nature Photonics and Light: Science & Applications and served on the Photonics Online Meetup 2023 committee, fostering collaboration among 100 attendees and 24 organizations.
- Academic
- Deputy Head Of School, Research
- Biomedical Engineering Discipline
- Deputy Head Of School, ResearchBiomedical Engineering Discipline
Wei Deng is an Associate Professor in the School of Biomedical Engineering at UTS. She made outstanding contributions to the advancement of cancer nanotechnology field. Her team’s pioneering transdisciplinary research spans nanobiotechnology, oncology, gene engineering and medical science to create new technologies for cancer and genetic disorder treatment. A notable example is the development of radiation-activated chemotherapy (RAC) via the bespoke liposomes (US Patent No. 12036282, Europe Patent No. 3720422), an innovative treatment method for rectal cancer patients. Through her pioneering work on RAC, Deng has enabled the synchronous action of chemotherapy and radiation, allowing cytotoxic drugs to be released predominantly within the tumour site, significantly reducing the toxicity to healthy tissues. This has led to paradigm shifting knowledge impact in the field of cancer treatments and providing new hope for patients who no longer benefit from standard-of-care chemo/radiotherapy due to due to its harmful effects on bowel function.
Deng has 91 refereed journal publications, three PCT applications and two granted patents (US, Europe and Australia), with 35% as 1st and 50% a senior author. They are on an upward trajectory for citations (h-index, 31, Google Scholar). 92% of journals are in the 1st quartile (Citescore Quartiles) for their category. A/Prof Deng attracted over $7.2 million of Australian competitive funding from ARC, NHMRC, Cancer Institute NSW, NSW Health and other foundations.
The commercial potential of Deng's work is evidenced by developing precise gene therapy solution to address the treatment burden of macular disease, in partnership with Ocular BioMedical Ltd. She also has contributed to the development of CRISPR-based sensor for the detection of pathogens in water and waste water, in partnership with UNSW and BioPoint Ltd, through the support of NSW Smart Sensing Network.Wei Deng is an Associate Professor in the School of Biomedical Engineering at UTS. She made outstanding contributions to the advancement of cancer nanotechnology field. Her team’s pioneering transdisciplinary research spans nanobiotechnology, oncology, gene engineering and medical science to create new technologies for cancer and genetic disorder treatment. A notable example is the development of radiation-activated chemotherapy (RAC) via the bespoke liposomes (US Patent No. 12036282, Europe Patent No. 3720422), an innovative treatment method for rectal cancer patients. Through her pioneering work on RAC, Deng has enabled the synchronous action of chemotherapy and radiation, allowing cytotoxic drugs to be released predominantly within the tumour site, significantly reducing the toxicity to healthy tissues. This has led to paradigm shifting knowledge impact in the field of cancer treatments and providing new hope for patients who no longer benefit from standard-of-care chemo/radiotherapy due to due to its harmful effects on bowel function.
Deng has 91 refereed journal publications, three PCT applications and two granted patents (US, Europe and Australia), with 35% as 1st and 50% a senior author. They are on an upward trajectory for citations (h-index, 31, Google Scholar). 92% of journals are in the 1st quartile (Citescore Quartiles) for their category. A/Prof Deng attracted over $7.2 million of Australian competitive funding from ARC, NHMRC, Cancer Institute NSW, NSW Health and other foundations.
The commercial potential of Deng's work is evidenced by developing precise gene therapy solution to address the treatment burden of macular disease, in partnership with Ocular BioMedical Ltd. She also has contributed to the development of CRISPR-based sensor for the detection of pathogens in water and waste water, in partnership with UNSW and BioPoint Ltd, through the support of NSW Smart Sensing Network.- Academic
- Masters Research or PhD student supervision
Disciplines- Nanomedicine
- Gene and molecular therapy
- Nanobiotechnology
- Lecturer
- Biomedical Engineering Discipline
- LecturerBiomedical Engineering Discipline
Dr Ali Entezari is a Lecturer within the School of Biomedical Engineering at the University of Technology Sydney. Dr Entezari received his PhD from The University of Sydney. He is the recipient of three prestigious international fellowships, including a Fulbright Postdoctoral Fellowship, a Humboldt Research Fellowship, and a Marie Skłodowska-Curie Postdoctoral fellowship.
Dr Entezari’s primary research interests include computational modelling, biomechanics, mechanical design, tissue engineering, additive manufacturing, and medical device development.Dr Ali Entezari is a Lecturer within the School of Biomedical Engineering at the University of Technology Sydney. Dr Entezari received his PhD from The University of Sydney. He is the recipient of three prestigious international fellowships, including a Fulbright Postdoctoral Fellowship, a Humboldt Research Fellowship, and a Marie Skłodowska-Curie Postdoctoral fellowship.
Dr Entezari’s primary research interests include computational modelling, biomechanics, mechanical design, tissue engineering, additive manufacturing, and medical device development.- Academic
- Collaborative projects
- Industry Projects
- Masters Research or PhD student supervision
- Research Fellow
- Biomedical Engineering Discipline
- Research FellowBiomedical Engineering Discipline
Dr. Guocheng Fang is a Cancer Institute Early Career Fellow at the School of Biomedical Engineering, University of Technology Sydney (UTS). He is also a visiting Fellow at the Institute for Biomedical Materials and Devices (IBMD), School of Mathematical and Physical Sciences. Prior to joining UTS, he was a Presidential Postdoctoral Fellow (PPF) at the Nanyang Technological University, Singapore (2022-2024). He completed his PhD at Faculty of Science, University of Technology Sydney, from 2017 to 2021.
Dr. Fang envisions harnessing engineering innovations to address critical medical and clinical challenges, ultimately advancing human health and well-being. Currently, his research focuses on the intelligent organoid-on-chip systems, aiming to establish reliable and responsive platforms for disease modeling, drug screening, and man–machine interfacing. This encompasses four key areas:
1. Organ/Organoid-on-Chip Model: Engineering 3D multicellular models (e.g. intestine-on-a-chip, tumor-on-a-chip) on microfluidic platforms to recapitulate physiological functions and disease-related behaviors of native tissues and organs.
2. Biophotonic Sensor: Designing soft, minimally invasive sensors for real-time monitoring of organoid physiology, including mechanical stress, metabolic activity, and exosome secretion. These sensors primarily leverage optical microcavities, such as microlaser technology, to achieve high sensitivity and specificity.
3. Microfluidics: Developing advanced microfluidic technologies, including droplet-based systems and MEMS micro/nano fabrication techniques such as 3D printing and soft lithography.
4. Artificial Intelligence: Establishing machine learning algorithms for automated analysis of cellular and organoid data, enabling high-throughput drug screening and precision phenotyping.
Dr Fang’s research excellence is evidenced by a growing number of publications in prominent journals. Since 2017, he has published > 50 peer-reviewed scientific articles, such as Nature Communications, PNAS, Advanced Materials, ACS Nano, Nano Letters, Biofabrication, Biosensors & Bioelectronics, and Lab on a Chip. His work has garnered > 1500 citations and achieved an H-index of 22 (as of July 2026). In the past five years, 81% of his works have been published in high-quality Q1 journals (SJR). His first-author paper on soft microlaser sensors featured on the cover page of the high-quality journal ACS Nano. Dr. Fang’s research has attracted >$2M in funding, serving as the lead Chief Investigator on two prestigious Fellowships, including Cancer Institute NSW fellowship (598,593 AUD) and NTU Presidential Postdoctoral Fellowship (PPF) (404,000 SGD, around 448,922 AUD).
Dr. Fang’s research has led to the granting of two U.S. patents and two international patents. His research has been featured in more than 40 media outlets, including CNA, Channel 5 News Singapore, Lianhe Zaobao, 8World News, Shin Min Daily News, Phys.org (UK), Photonics Online (US), Mirage News (AU), Lab+Life Scientist (AU), AZoLifeSciences (UK), uFluidix (CA), and Nanowerk (US). He also serves as a guest editor for the journals Frontiers in Bioengineering and Biotechnology and Sensors, and reviewer for esteemed journals such as Lab on a chip, Bioactive Materials, Journal of Nanobiotechnology, npj Nanophotonics, Photonics Research, Advanced Photonics.
Group members:
- Mr Yuhan Xia (PhD candidate, 2026-Present, joint supervision: David Gallego-Ortega)
- Mr Sina Ebrahimi Hasratanloo (PhD candidate, 2026-Present)
- Mrs Dan Shao (PhD candidate, 2024-Present, joint supervision: Dayong Jin)
- Mrs Ovi Kehan Cai (Visiting scholar, 2025-present, joint supervision: Gungun Lin)
- Mr Kenny Paek (Honors student, 2026-present, joint supervision: Helen Xu, Kristine McGrath)
- Mr Dong Yang (PhD candidate, to be start, joint supervision: Dayong Jin)
- Mrs Zoe Yan Ge (PhD candidate, to be start)
- Mr Zach Zhong (Visiting scholar, 2026-present)
Dr. Guocheng Fang is a Cancer Institute Early Career Fellow at the School of Biomedical Engineering, University of Technology Sydney (UTS). He is also a visiting Fellow at the Institute for Biomedical Materials and Devices (IBMD), School of Mathematical and Physical Sciences. Prior to joining UTS, he was a Presidential Postdoctoral Fellow (PPF) at the Nanyang Technological University, Singapore (2022-2024). He completed his PhD at Faculty of Science, University of Technology Sydney, from 2017 to 2021.
Dr. Fang envisions harnessing engineering innovations to address critical medical and clinical challenges, ultimately advancing human health and well-being. Currently, his research focuses on the intelligent organoid-on-chip systems, aiming to establish reliable and responsive platforms for disease modeling, drug screening, and man–machine interfacing. This encompasses four key areas:
1. Organ/Organoid-on-Chip Model: Engineering 3D multicellular models (e.g. intestine-on-a-chip, tumor-on-a-chip) on microfluidic platforms to recapitulate physiological functions and disease-related behaviors of native tissues and organs.
2. Biophotonic Sensor: Designing soft, minimally invasive sensors for real-time monitoring of organoid physiology, including mechanical stress, metabolic activity, and exosome secretion. These sensors primarily leverage optical microcavities, such as microlaser technology, to achieve high sensitivity and specificity.
3. Microfluidics: Developing advanced microfluidic technologies, including droplet-based systems and MEMS micro/nano fabrication techniques such as 3D printing and soft lithography.
4. Artificial Intelligence: Establishing machine learning algorithms for automated analysis of cellular and organoid data, enabling high-throughput drug screening and precision phenotyping.
Dr Fang’s research excellence is evidenced by a growing number of publications in prominent journals. Since 2017, he has published > 50 peer-reviewed scientific articles, such as Nature Communications, PNAS, Advanced Materials, ACS Nano, Nano Letters, Biofabrication, Biosensors & Bioelectronics, and Lab on a Chip. His work has garnered > 1500 citations and achieved an H-index of 22 (as of July 2026). In the past five years, 81% of his works have been published in high-quality Q1 journals (SJR). His first-author paper on soft microlaser sensors featured on the cover page of the high-quality journal ACS Nano. Dr. Fang’s research has attracted >$2M in funding, serving as the lead Chief Investigator on two prestigious Fellowships, including Cancer Institute NSW fellowship (598,593 AUD) and NTU Presidential Postdoctoral Fellowship (PPF) (404,000 SGD, around 448,922 AUD).
Dr. Fang’s research has led to the granting of two U.S. patents and two international patents. His research has been featured in more than 40 media outlets, including CNA, Channel 5 News Singapore, Lianhe Zaobao, 8World News, Shin Min Daily News, Phys.org (UK), Photonics Online (US), Mirage News (AU), Lab+Life Scientist (AU), AZoLifeSciences (UK), uFluidix (CA), and Nanowerk (US). He also serves as a guest editor for the journals Frontiers in Bioengineering and Biotechnology and Sensors, and reviewer for esteemed journals such as Lab on a chip, Bioactive Materials, Journal of Nanobiotechnology, npj Nanophotonics, Photonics Research, Advanced Photonics.
Group members:
- Mr Yuhan Xia (PhD candidate, 2026-Present, joint supervision: David Gallego-Ortega)
- Mr Sina Ebrahimi Hasratanloo (PhD candidate, 2026-Present)
- Mrs Dan Shao (PhD candidate, 2024-Present, joint supervision: Dayong Jin)
- Mrs Ovi Kehan Cai (Visiting scholar, 2025-present, joint supervision: Gungun Lin)
- Mr Kenny Paek (Honors student, 2026-present, joint supervision: Helen Xu, Kristine McGrath)
- Mr Dong Yang (PhD candidate, to be start, joint supervision: Dayong Jin)
- Mrs Zoe Yan Ge (PhD candidate, to be start)
- Mr Zach Zhong (Visiting scholar, 2026-present)
- Academic
- Masters Research or PhD student supervision
- Industry Projects
- Collaborative projects
- Associate Professor
- Signal Processing and Analytics Discipline
- Associate ProfessorSignal Processing and Analytics Discipline
I am an electrical engineer specialising in telecommunications and radiation engineering. I joined UTS in April 2011 after nearly a decade as a lecturer at the University of Wollongong. I have taught a variety of subjects in telecommunications engineering, IT and biomedical engineering, including communication protocols, Android programming, satellite communications system and biomedical instrumentation. My main research activities are focused on signal and image processing, Monte Carlo modelling for industrial and medical radiation engineering applications (including nuclear imaging and radiation therapy) and high-performance networks. I work with a wide range of industry partners, from the telecommunications sector to industrial and medical imaging system vendors, and have attracted several million dollars in industry funding.I am an electrical engineer specialising in telecommunications and radiation engineering. I joined UTS in April 2011 after nearly a decade as a lecturer at the University of Wollongong. I have taught a variety of subjects in telecommunications engineering, IT and biomedical engineering, including communication protocols, Android programming, satellite communications system and biomedical instrumentation. My main research activities are focused on signal and image processing, Monte Carlo modelling for industrial and medical radiation engineering applications (including nuclear imaging and radiation therapy) and high-performance networks. I work with a wide range of industry partners, from the telecommunications sector to industrial and medical imaging system vendors, and have attracted several million dollars in industry funding.- 3 Good Health and Well Being
- 7 Affordable and Clean Energy
- 9 Industry, Innovation and Infrastructure
- 2 Zero Hunger
- Academic
- Masters Research or PhD student supervision
Disciplines- Biomedical imaging
- Communications engineering
- Radiation therapy
- Network engineering
- Professor & Director, Single Cell Genomics Facility
- Biomedical Engineering Discipline
- Professor & Director, Single Cell Genomics FacilityBiomedical Engineering Discipline
I was awarded my PhD in Biochemistry, Molecular Biology and Biomedicine in July 2008 at the Universidad Autonoma de Madrid in Spain. After a brief position at TCD Pharma, a biotechnology spin-off company, I moved to the Garvan Institute of Medical Research in 2009 to pursue postdoctoral studies on mammary gland development and breast cancer. My postdoc at the Garvan provided me with a deep technical and conceptual foundation for mammary gland biology and how deregulation of developmental pathways contributes to breast cancer. During this stage, I also developed a strong interest in mechanisms of communication between different cellular compartments within the tissue ecosystem, which in turn set the foundations for establishing my research group and independent career direction in 2015.
Early career - I was awarded a 4-year early career Fellowship from the National Breast Cancer Foundation / co-sponsored by the Cure Cancer Research Foundation (2012-2016). During this stage of my career, I also participated as co-investigator in several successful grant applications, contributing to their design, writing and generation of preliminary data (2 NHMRC grants $1,62M, and 3 CINSW equipment grants $1M).
Mid-career - The direction of my independent scientific career led me to join the emerging field of single-cell genomics and this underpinned the award of a Cancer Institute NSW Career Development Fellowship (2017-2019). The leadership in the early adoption and development of new single-cell RNAseq technology led to co-lead the inception of the Garvan-Weizmann Centre for Cellular Genomics at the Garvan Institute. The successful deployment of these technologies has fast-tracked my research, attracting $1.75M of independent competitive funding since 2017 (CINSW fellowship 2017, CCNSW project grant 2018 and SPHERE CAG UNSW grant 2019, UNSW 3R grant 2020).I was awarded my PhD in Biochemistry, Molecular Biology and Biomedicine in July 2008 at the Universidad Autonoma de Madrid in Spain. After a brief position at TCD Pharma, a biotechnology spin-off company, I moved to the Garvan Institute of Medical Research in 2009 to pursue postdoctoral studies on mammary gland development and breast cancer. My postdoc at the Garvan provided me with a deep technical and conceptual foundation for mammary gland biology and how deregulation of developmental pathways contributes to breast cancer. During this stage, I also developed a strong interest in mechanisms of communication between different cellular compartments within the tissue ecosystem, which in turn set the foundations for establishing my research group and independent career direction in 2015.
Early career - I was awarded a 4-year early career Fellowship from the National Breast Cancer Foundation / co-sponsored by the Cure Cancer Research Foundation (2012-2016). During this stage of my career, I also participated as co-investigator in several successful grant applications, contributing to their design, writing and generation of preliminary data (2 NHMRC grants $1,62M, and 3 CINSW equipment grants $1M).
Mid-career - The direction of my independent scientific career led me to join the emerging field of single-cell genomics and this underpinned the award of a Cancer Institute NSW Career Development Fellowship (2017-2019). The leadership in the early adoption and development of new single-cell RNAseq technology led to co-lead the inception of the Garvan-Weizmann Centre for Cellular Genomics at the Garvan Institute. The successful deployment of these technologies has fast-tracked my research, attracting $1.75M of independent competitive funding since 2017 (CINSW fellowship 2017, CCNSW project grant 2018 and SPHERE CAG UNSW grant 2019, UNSW 3R grant 2020).- Academic
- Masters Research or PhD student supervision
Disciplines- Biomedical engineering
- Genetics
- Oncology and carcinogenesis
- Associate Professor
- Biomedical Engineering Discipline
- Associate ProfessorBiomedical Engineering Discipline
Assoc/Prof Carmine Gentile, PharmD/PhD, FAHA, leads the Cardiovascular Regeneration Group, working on 3D bioprinting and stem cell technologies both at the Heart Research Institute and UTS. He is an Associate Professor (Faculty) within the School of Biomedical Engineering (Faculty of Engineering and IT) at the University of Technology Sydney.
He received his BSc/MSc (Pharmaceutical Chemistry and Technologies) and PharmD at the University of Pisa, Italy, and his PhD in Biomedical Sciences (Cardiovascular) at the Medical University of South Carolina, Charleston, SC, USA, funded by a prestigious American Heart Association Fellowship.
Since 2013, A/Prof Gentile has worked in Australia at the Heart Research Institute, the University of Sydney, and now at UTS, supported by several awards and grants, working within a multidisciplinary team with scientists, industry partners, and clinicians to quickly translate his findings from bench to bedside.
Assoc/Prof Gentile is an internationally recognized expert in the field of 3D bioprinting and stem cell technologies, and his more recent studies focus on novel molecular and cellular approaches to treat cardiovascular disease, including myocardial infarction and heart failure. These studies are based on the use of “mini-hearts” he developed as “bioink” for human heart tissues. In 2016, he was invited as a Visiting Research Fellow at Harvard Medical School, where he worked towards novel in-vitro models using mini-hearts to study human heart physiology.Assoc/Prof Carmine Gentile, PharmD/PhD, FAHA, leads the Cardiovascular Regeneration Group, working on 3D bioprinting and stem cell technologies both at the Heart Research Institute and UTS. He is an Associate Professor (Faculty) within the School of Biomedical Engineering (Faculty of Engineering and IT) at the University of Technology Sydney.
He received his BSc/MSc (Pharmaceutical Chemistry and Technologies) and PharmD at the University of Pisa, Italy, and his PhD in Biomedical Sciences (Cardiovascular) at the Medical University of South Carolina, Charleston, SC, USA, funded by a prestigious American Heart Association Fellowship.
Since 2013, A/Prof Gentile has worked in Australia at the Heart Research Institute, the University of Sydney, and now at UTS, supported by several awards and grants, working within a multidisciplinary team with scientists, industry partners, and clinicians to quickly translate his findings from bench to bedside.
Assoc/Prof Gentile is an internationally recognized expert in the field of 3D bioprinting and stem cell technologies, and his more recent studies focus on novel molecular and cellular approaches to treat cardiovascular disease, including myocardial infarction and heart failure. These studies are based on the use of “mini-hearts” he developed as “bioink” for human heart tissues. In 2016, he was invited as a Visiting Research Fellow at Harvard Medical School, where he worked towards novel in-vitro models using mini-hearts to study human heart physiology.- 3 Good Health and Well Being
- 9 Industry, Innovation and Infrastructure
- 8 Decent Work and Economic Growth
- 12 Responsible Consumption and Production
- 13 Climate Action
- 4 Quality Education
- 17 Partnerships for the Goals
- 5 Gender Equality
- 7 Affordable and Clean Energy
- 11 Sustainable Cities and Communities
- 10 Reduced Inequalities
- Academic
- Career advice
- Collaborative projects
- Join a web conference as a panellist or speaker
- Masters Research or PhD student supervision
- Media enquiries
- Membership of an advisory committee
- Mentoring (long-term)
- Mentoring (short-term)
- Teaching provision
- Technical support
- Industry Projects
Disciplines- Biomedical engineering
- Cardiology (incl. cardiovascular diseases)
- Regenerative medicine (incl. stem cells)
- Graduate Research Student
- School of Biomedical Engineering
- Graduate Research StudentSchool of Biomedical Engineering
- Higher Degree by Research
- Professor
- Biomedical Engineering Discipline
- ProfessorBiomedical Engineering Discipline
Professor Gyorgy Hutvagner obtained his MSc from Biotechnology and PhD from Biology in Hungary.
He has completed his postdoctoral training in The Netherlands (Plant Research International, Wageningen, 1999-2001) and in the U.S. (University of Massachusetts, Medical School, 2001-2005) winning several national and international short-term and long term fellowships.
He established his own research group in 2005 in Dundee with the support of the Wellcome Trust Career Development Fellowship and the European Framework 6 grant SIROCCO. He moved to the UTS in 2011 and accepted a position at the Faculty of Engineering and Information Technology. In 2011 he was awarded with the prestigious ARC Future Fellowship.Professor Gyorgy Hutvagner obtained his MSc from Biotechnology and PhD from Biology in Hungary.
He has completed his postdoctoral training in The Netherlands (Plant Research International, Wageningen, 1999-2001) and in the U.S. (University of Massachusetts, Medical School, 2001-2005) winning several national and international short-term and long term fellowships.
He established his own research group in 2005 in Dundee with the support of the Wellcome Trust Career Development Fellowship and the European Framework 6 grant SIROCCO. He moved to the UTS in 2011 and accepted a position at the Faculty of Engineering and Information Technology. In 2011 he was awarded with the prestigious ARC Future Fellowship.- Academic
- Masters Research or PhD student supervision
Disciplines- Biomedical engineering
- Genetics
- Postdoctoral Research Fellow
- Signal Processing and Analytics Discipline
- Postdoctoral Research FellowSignal Processing and Analytics Discipline
Dr. Inigo Jauregi Unanue is a Postdoctoral Research Fellow at the Telecom Research Institute (TRI) at University of Technology Sydney, specializing in machine learning and natural language processing (NLP). Beyond academia, he brings 10 years of industry experience as a data scientist across diverse domains including finance, property valuation, IoT sensors, and fraud analysis. He is also co-founder and director of Sendatu Therapeutics, an Australian start-up developing AI-driven gene therapies.
Inigo Jauregi Unanue's research is in natural language processing, with a particular focus on large language models (LLMs). His current work is on aligning and steering LLMs: using preference optimisation and representation editing to control what models generate, and building methods that make their behaviour more reliable, controllable and suited to specific needs. This builds on a long-standing interest in how training objectives shape language models, including reinforcement learning rewards, differentiable training pipelines and adversarial training, applied to text generation, summarisation and classification. A central thread is multilinguality. He has worked extensively on neural machine translation, including discourse-aware and attribute-controlled translation and translation for low-resource languages and specialised fields like Basque and biomedical text. He also works on cross-lingual transfer, so that the benefits of language models reach languages beyond English. More recently, he has extended this to multilingual and code-switched speech in the medical domain.
Inigo's research has been published at the leading venues in natural language processing, including ACL, NAACL, EACL, COLING, LREC and the journal Transactions of the Association for Computational Linguistics (TACL). His work has helped improve machine translation for languages and domains with few resources, including Basque and biomedical text. He has also contributed to the community as a co-author of the findings of the WMT Biomedical Translation Shared Task, an international benchmark for evaluating medical translation systems. His methods for training and controlling language models, from fine-tuning translation models with semantic metrics to steering LLMs with preference optimisation and representation editing, address the broader challenge of making language technologies more accurate, controllable and useful across many languages and specialised fields such as healthcare.
Dr. Inigo Jauregi Unanue is a Postdoctoral Research Fellow at the Telecom Research Institute (TRI) at University of Technology Sydney, specializing in machine learning and natural language processing (NLP). Beyond academia, he brings 10 years of industry experience as a data scientist across diverse domains including finance, property valuation, IoT sensors, and fraud analysis. He is also co-founder and director of Sendatu Therapeutics, an Australian start-up developing AI-driven gene therapies.
Inigo Jauregi Unanue's research is in natural language processing, with a particular focus on large language models (LLMs). His current work is on aligning and steering LLMs: using preference optimisation and representation editing to control what models generate, and building methods that make their behaviour more reliable, controllable and suited to specific needs. This builds on a long-standing interest in how training objectives shape language models, including reinforcement learning rewards, differentiable training pipelines and adversarial training, applied to text generation, summarisation and classification. A central thread is multilinguality. He has worked extensively on neural machine translation, including discourse-aware and attribute-controlled translation and translation for low-resource languages and specialised fields like Basque and biomedical text. He also works on cross-lingual transfer, so that the benefits of language models reach languages beyond English. More recently, he has extended this to multilingual and code-switched speech in the medical domain.
Inigo's research has been published at the leading venues in natural language processing, including ACL, NAACL, EACL, COLING, LREC and the journal Transactions of the Association for Computational Linguistics (TACL). His work has helped improve machine translation for languages and domains with few resources, including Basque and biomedical text. He has also contributed to the community as a co-author of the findings of the WMT Biomedical Translation Shared Task, an international benchmark for evaluating medical translation systems. His methods for training and controlling language models, from fine-tuning translation models with semantic metrics to steering LLMs with preference optimisation and representation editing, address the broader challenge of making language technologies more accurate, controllable and useful across many languages and specialised fields such as healthcare.
- Academic
- Associate Professor
- Signal Processing and Analytics Discipline
- Associate ProfessorSignal Processing and Analytics Discipline
Dr. Wenjing Jia is an Associate Professor at the Faculty of Engineering and Information Technology (FEIT), University of Technology Sydney (UTS), and an internationally recognised researcher in Artificial Intelligence (AI) and Image Analysis with over 18 years of professional experience. She is the founder and leader of the AI-empowered Digital Twin Lab at the Global Big Data Technologies Centre (GBDTC), UTS, where she leads a multidisciplinary team tackling complex real-world challenges. Her research focuses on building interactive Digital Twin models that transform massive, real-time data streams into actionable digital intelligence through advanced AI and data visualisation techniques. These innovations are driving transformative solutions for government, industry, and society, with applications spanning telecommunications, IoT, public safety, health, and critical infrastructure resilience.
Dr. Jia has successfully led numerous high-impact research projects for government, industry, and academia, attracting over $5 million in competitive funding. Her work addresses real-world problems such as Flood Intelligence Digital Twin, Power Resilient Telecom Digital Twin, medical image analysis, remote sensing, violence detection, crowd analytics, and text information extraction. She has published over 170 scientific papers in prestigious journals and conferences, including ICML, CVPR, AAAI, IEEE-TIP, IEEE-TMM, IEEE-TCSVT and IEEE-TGRS, and has received multiple awards, such as the Excellent Thesis Award and Science and Technology Awards, and a Finalist for the UTS Vice-Chancellor's Research Excellence Awards. She has also played a key role in organising major international conferences, including ICPR, ICDAR 2019, TrustCom 2017, MMM 2015, and CIT 2008, strengthening global research collaboration.
As a highly regarded educator with more than 20 years of teaching experience, Dr. Jia has consistently received outstanding student feedback and earned two Teaching & Learning grants as Lead Chief Investigator. She serves as the Main Contact for UTS Cisco Networking Academy, engaging with the global Cisco community and delivering instructor-training programs as a Cisco Certified Instructor Trainer. Her dedication to education was recognised when she was named a Finalist for the inaugural Cisco Women in IT Academia Award (2019).
Dr. Jia’s leadership extends beyond research and teaching to academic administration and industry engagement. She has served as the Major Coordinator for the popular IT undergraduate majors Networking and Cybersecurity, managed international partnerships, and contributed significantly to curriculum innovation. Her secondment and acting roles as Deputy Head of School (Teaching and Learning) in 2016-2017 and 2025-2026 demonstrated her outstanding academic leadership in managing large academic teams, developing new programs, and revitalising existing offerings.
In summary, Dr. Wenjing Jia is a committed educator and visionary researcher whose work in AI and Digital Twin technologies is shaping the future of smart systems and big data intelligence. Her proven track record in research leadership, industry collaboration, and academic excellence positions her as a key contributor to technological innovation and societal impact.
Dr. Wenjing Jia is an Associate Professor at the Faculty of Engineering and Information Technology (FEIT), University of Technology Sydney (UTS), and an internationally recognised researcher in Artificial Intelligence (AI) and Image Analysis with over 18 years of professional experience. She is the founder and leader of the AI-empowered Digital Twin Lab at the Global Big Data Technologies Centre (GBDTC), UTS, where she leads a multidisciplinary team tackling complex real-world challenges. Her research focuses on building interactive Digital Twin models that transform massive, real-time data streams into actionable digital intelligence through advanced AI and data visualisation techniques. These innovations are driving transformative solutions for government, industry, and society, with applications spanning telecommunications, IoT, public safety, health, and critical infrastructure resilience.
Dr. Jia has successfully led numerous high-impact research projects for government, industry, and academia, attracting over $5 million in competitive funding. Her work addresses real-world problems such as Flood Intelligence Digital Twin, Power Resilient Telecom Digital Twin, medical image analysis, remote sensing, violence detection, crowd analytics, and text information extraction. She has published over 170 scientific papers in prestigious journals and conferences, including ICML, CVPR, AAAI, IEEE-TIP, IEEE-TMM, IEEE-TCSVT and IEEE-TGRS, and has received multiple awards, such as the Excellent Thesis Award and Science and Technology Awards, and a Finalist for the UTS Vice-Chancellor's Research Excellence Awards. She has also played a key role in organising major international conferences, including ICPR, ICDAR 2019, TrustCom 2017, MMM 2015, and CIT 2008, strengthening global research collaboration.
As a highly regarded educator with more than 20 years of teaching experience, Dr. Jia has consistently received outstanding student feedback and earned two Teaching & Learning grants as Lead Chief Investigator. She serves as the Main Contact for UTS Cisco Networking Academy, engaging with the global Cisco community and delivering instructor-training programs as a Cisco Certified Instructor Trainer. Her dedication to education was recognised when she was named a Finalist for the inaugural Cisco Women in IT Academia Award (2019).
Dr. Jia’s leadership extends beyond research and teaching to academic administration and industry engagement. She has served as the Major Coordinator for the popular IT undergraduate majors Networking and Cybersecurity, managed international partnerships, and contributed significantly to curriculum innovation. Her secondment and acting roles as Deputy Head of School (Teaching and Learning) in 2016-2017 and 2025-2026 demonstrated her outstanding academic leadership in managing large academic teams, developing new programs, and revitalising existing offerings.
In summary, Dr. Wenjing Jia is a committed educator and visionary researcher whose work in AI and Digital Twin technologies is shaping the future of smart systems and big data intelligence. Her proven track record in research leadership, industry collaboration, and academic excellence positions her as a key contributor to technological innovation and societal impact.
- Academic
- Masters Research or PhD student supervision
Disciplines- Computer vision
- Image processing
- Computer vision and multimedia computation
- Associate Professor
- Biomedical Engineering Discipline
- Associate ProfessorBiomedical Engineering Discipline
As a biomedical engineer working in tissue engineering and regenerative medicine, Dr Jiao Jiao Li (JJ) envisions a future where stem cells and bioactive materials can be ‘personalised’ to provide optimal treatments for major diseases. Leading a research team in biomedical engineering, she is developing regenerative therapies for musculoskeletal diseases such as osteoarthritis and bone conditions – debilitating diseases affecting hundreds of millions of people, old and young across the globe.
JJ loves working with people from around the world with different backgrounds, skills and experiences to jointly solve medical challenges, and passing on the passion of creating STEM solutions to the next generation. Her work has attracted fellowships from Rebecca L Cooper Medical Research Foundation, National Health and Medical Research Council (NHMRC), and Endeavour Research program; citations placing her in the Stanford/Elsevier list of world's top 2% scientists in 2025 & 2026; best research awards from international (e.g., TERMIS) and national societies (e.g., ANZBMS, ASBTE, ASMR, ANZORS, MBSANZ, AWTRS); and >30 awards for her publications and conference presentations. She was winner of the Sydney Professional Engineer of the Year in 2026; Eureka Prize for Emerging Leader in Science in 2024; female winner of the Metcalf Prize for Stem Cell Research in 2023 (with live interview on ABC News Breakfast); NSW Young Tall Poppy Scientist of the Year & Premier's Prize for NSW Early Career Researcher of the Year (Physical Sciences) in 2022; and the Australian winner of Falling Walls Lab in 2021. She was also a chief investigator and Co-Deputy Director of the Australian Research Council Training Centre for Innovative BioEngineering. JJ is passionate about promoting STEM to the public community, which is further enabled by her roles as Board Director of Australian Institute of Policy & Science (AIPS), as well as past Board Director, Chair of the Equity, Diversity & Inclusion Committee, and a 2021-22 Superstar of STEM of Science & Technology Australia.
JJ was elected Fellow of the Royal Society of NSW (FRSN) in 2023, Fellow of the Royal Society of Biology (FRSB) in 2024, and Fellow of Engineers Australia (FIEAust) in 2025. She was appointed as a member of the Australian Research Council Advisory Committee in 2025. She has been serving on the Biomedical College Board & Biomedical College Sydney Branch Committee Chair of Engineers Australia since 2026.
Inter/national awards and honours:
2025-30 Rebecca L Cooper Medical Research Foundation Al & Val Rosenstrauss Fellowship
2017-22 NHMRC Early Career Fellowship
2018-22 Chief Investigator, ARC Training Centre for Innovative BioEngineering; Co-Deputy Director since 2021
2021-22 Superstar of STEM, Science and Technology Australia2025 Fellow of Engineers Australia (FIEAust)
2024 Fellow of the Royal Society of Biology (FRSB)
2023 Fellow of the Royal Society of New South Wales (FRSN)2025 & 2026 Stanford/Elsevier list of world's top 2% scientists
2026 Professional Engineer of the Year - Sydney Winner, Engineers Australia
2026 Scientific Research Award, Women of Colour in STEM Awards
2024 Eureka Prize for Emerging Leader in Science
2023 Metcalf Prize for Stem Cell Research, National Stem Cell Foundation of Australia
2023 Winner, Australia China Alumni Award for Research & Science, Australia China Alumni Association (ACAA)
2022 Young Investigator Award, Tissue Engineering & Regenerative Medicine International Society (TERMIS) (1 of 2 awardees in Asia-Pacific)
2022 NSW Early Career Researcher of the Year (Physical Sciences), Premier's Prizes for Science & Engineering
2022 NSW Young Tall Poppy Scientist of the Year, Australian Institute of Policy and Science (AIPS)
2022 Australia's Top 20 Under 40 Researchers, featured in Daily Telegraph & Herald Sun (Aug 2022)2021 Winner, Falling Walls Lab Australia (also Australian rep in global final)
Society awards and other recognitions:2026 Mid-Career Plenary Award, Australian & New Zealand Bone and Mineral Society (ANZBMS)
2025 Emerging Investigator Award, Australasian Society for Biomaterials and Tissue Engineering (ASBTE)
2025 Kaye Ibbertson Award for Bone & Mineral Medicine, Australian & New Zealand Bone and Mineral Society (ANZBMS)
2024 Research Excellence Award, Australian Association of Chinese Biomedical Scientists (AACBS)
2022 Alan Skyring Memorial Award, Australian Society for Medical Research (ASMR)
2022 Minghao Zheng Orthopaedic Innovation Award, Australian and New Zealand Orthopaedic Research Society (ANZORS)
2020 Bob Fraser New Investigator Award, Matrix Biology Society of Australia and New Zealand (MBSANZ)
2019 Young Investigator of the Year Award, Australasian Wound & Tissue Repair Society (AWTRS)2021 Finalist, Research Australia Discovery Award (top 6 nationally)
2022/21 Shortlisted for L'Oréal-UNESCO Australia & New Zealand For Women in Science Fellowship
2025 Bioactive Materials Best Paper Award
2023/20/21 Matrix Biology Society of Australia and New Zealand (MBSANZ) Paper of the Month Award (Jun 2023, Jan 2021, Oct 2020)
2019 Institute of Bone and Joint Research (IBJR) Basic Science Manuscript Award
2017 Rebecca L. Cooper Medical Research Foundation Medal
2016 Award of Excellence, University of Sydney
2011 Endeavour Research Fellowship, awarded by Australian Government to undertake research at Tufts University, USA
2010 6-Degrees of Freedom Award, Sydney Orthopaedic Research Institute (SORI) for the top Honours thesis in Biomedical Engineering
2010 University Medal, Bachelor of Engineering (Biomedical) / Bachelor of Medical Science, University of Sydney
2010-2021 20 conference best presentation awards, including at notable international (e.g., OARSI China Evening 2019; TERMIS-AP 2016) and national (e.g., AWTRS 2021, 2020; ASMR NSW 2020, 2018; ANZORS 2013) conferences; 16 travel grants to international and national conferencesCommittee roles for scientific/professional agencies and societies:
International:
- Tissue Engineering & Regenerative Medicine International Society (TERMIS) global Editorial Committee (2022–now)- TERMIS-AP Council Member (2026–now)
- Osteoarthritis Research Society International (OARSI) Communications Committee (2022–now) & Chair (2025–now), Early Career Investigator Committee (2019–2023), Diversity, Equity, Inclusion (DEI) Task Force (2022)
- Orthopaedic Research Society (ORS) Career Development Committee (2024–now)- ORS Ambassador for Australia (2026–now)
- International Federation of Musculoskeletal Research Societies (IFMRS), Future Global Leaders Committee (2024–now)National:
- Australian Research Council (ARC) Advisory Committee member (2025–now)
- Engineers Australia, Biomedical College Board & Biomedical College Sydney Branch Committee Chair (2026–now)
- Australian Academy of Technological Sciences & Engineering (ATSE), Emerging Leader/Health & Medical Technology Forum Member (2026–now)
- Science in Australia Gender Equity (SAGE), Lived Experience Advisory Panel (2026–now)
- Australian Institute of Policy and Science (AIPS), Board Director (2024–now)
- Science & Technology Australia, Board Director (2022–2025) & Equity, Diversity and Inclusion (EDI) Committee Chair (2023–2025)
- Australasian Society for Biomaterials and Tissue Engineering (ASBTE) Executive Committee (2025–now)
- Australian & New Zealand Bone and Mineral Society (ANZBMS) Early Career Investigator Committee (2020–2022), Communications Committee (2022–now)
- Australia & New Zealand Society for Extracellular Vesicles (ANZSEV), Executive Committee & Conference Co-Chair (2025)
- Australasian Wound & Tissue Repair Society (AWTRS) General Committee (2021–2024)
- Matrix Biology Society of Australia & New Zealand (MBSANZ) Executive Committee (2021–2024)
- Australian Academy of Science EMCR Forum Representative Network (2020–2021)
- Australian Society for Medical Research (ASMR) NSW Committee (2019–2020)Institution:
- UTS Representative, Global Challenge in Higher Education and Research (GHEAR) Steering Group, Worldwide Universities Network (WUN) (2022–2023)
- UTS Gender Equity Staff Ambassador (2020–now)
- Sydney Nano ECR Ambassador (2019–2021)
- Royal North Shore Hospital Scientific Staff Council Deputy Chair (2019) & Executive Committee (2018–2019)Editorial roles (selected):
- Editorial Board, Biomedical Materials (2026–now)
- International Editorial Board, Journal of Orthopaedic Translation (2026–now)
- Associate Editor, Cartilage (2024–now)
- Editorial Advisory Board, ACS Biomaterials Science & Engineering (2024–now)
- Young Investigator Council and Editorial Board of Tissue Engineering, Parts A, B, & C (2016–2019)As a biomedical engineer working in tissue engineering and regenerative medicine, Dr Jiao Jiao Li (JJ) envisions a future where stem cells and bioactive materials can be ‘personalised’ to provide optimal treatments for major diseases. Leading a research team in biomedical engineering, she is developing regenerative therapies for musculoskeletal diseases such as osteoarthritis and bone conditions – debilitating diseases affecting hundreds of millions of people, old and young across the globe.
JJ loves working with people from around the world with different backgrounds, skills and experiences to jointly solve medical challenges, and passing on the passion of creating STEM solutions to the next generation. Her work has attracted fellowships from Rebecca L Cooper Medical Research Foundation, National Health and Medical Research Council (NHMRC), and Endeavour Research program; citations placing her in the Stanford/Elsevier list of world's top 2% scientists in 2025 & 2026; best research awards from international (e.g., TERMIS) and national societies (e.g., ANZBMS, ASBTE, ASMR, ANZORS, MBSANZ, AWTRS); and >30 awards for her publications and conference presentations. She was winner of the Sydney Professional Engineer of the Year in 2026; Eureka Prize for Emerging Leader in Science in 2024; female winner of the Metcalf Prize for Stem Cell Research in 2023 (with live interview on ABC News Breakfast); NSW Young Tall Poppy Scientist of the Year & Premier's Prize for NSW Early Career Researcher of the Year (Physical Sciences) in 2022; and the Australian winner of Falling Walls Lab in 2021. She was also a chief investigator and Co-Deputy Director of the Australian Research Council Training Centre for Innovative BioEngineering. JJ is passionate about promoting STEM to the public community, which is further enabled by her roles as Board Director of Australian Institute of Policy & Science (AIPS), as well as past Board Director, Chair of the Equity, Diversity & Inclusion Committee, and a 2021-22 Superstar of STEM of Science & Technology Australia.
JJ was elected Fellow of the Royal Society of NSW (FRSN) in 2023, Fellow of the Royal Society of Biology (FRSB) in 2024, and Fellow of Engineers Australia (FIEAust) in 2025. She was appointed as a member of the Australian Research Council Advisory Committee in 2025. She has been serving on the Biomedical College Board & Biomedical College Sydney Branch Committee Chair of Engineers Australia since 2026.
Inter/national awards and honours:
2025-30 Rebecca L Cooper Medical Research Foundation Al & Val Rosenstrauss Fellowship
2017-22 NHMRC Early Career Fellowship
2018-22 Chief Investigator, ARC Training Centre for Innovative BioEngineering; Co-Deputy Director since 2021
2021-22 Superstar of STEM, Science and Technology Australia2025 Fellow of Engineers Australia (FIEAust)
2024 Fellow of the Royal Society of Biology (FRSB)
2023 Fellow of the Royal Society of New South Wales (FRSN)2025 & 2026 Stanford/Elsevier list of world's top 2% scientists
2026 Professional Engineer of the Year - Sydney Winner, Engineers Australia
2026 Scientific Research Award, Women of Colour in STEM Awards
2024 Eureka Prize for Emerging Leader in Science
2023 Metcalf Prize for Stem Cell Research, National Stem Cell Foundation of Australia
2023 Winner, Australia China Alumni Award for Research & Science, Australia China Alumni Association (ACAA)
2022 Young Investigator Award, Tissue Engineering & Regenerative Medicine International Society (TERMIS) (1 of 2 awardees in Asia-Pacific)
2022 NSW Early Career Researcher of the Year (Physical Sciences), Premier's Prizes for Science & Engineering
2022 NSW Young Tall Poppy Scientist of the Year, Australian Institute of Policy and Science (AIPS)
2022 Australia's Top 20 Under 40 Researchers, featured in Daily Telegraph & Herald Sun (Aug 2022)2021 Winner, Falling Walls Lab Australia (also Australian rep in global final)
Society awards and other recognitions:2026 Mid-Career Plenary Award, Australian & New Zealand Bone and Mineral Society (ANZBMS)
2025 Emerging Investigator Award, Australasian Society for Biomaterials and Tissue Engineering (ASBTE)
2025 Kaye Ibbertson Award for Bone & Mineral Medicine, Australian & New Zealand Bone and Mineral Society (ANZBMS)
2024 Research Excellence Award, Australian Association of Chinese Biomedical Scientists (AACBS)
2022 Alan Skyring Memorial Award, Australian Society for Medical Research (ASMR)
2022 Minghao Zheng Orthopaedic Innovation Award, Australian and New Zealand Orthopaedic Research Society (ANZORS)
2020 Bob Fraser New Investigator Award, Matrix Biology Society of Australia and New Zealand (MBSANZ)
2019 Young Investigator of the Year Award, Australasian Wound & Tissue Repair Society (AWTRS)2021 Finalist, Research Australia Discovery Award (top 6 nationally)
2022/21 Shortlisted for L'Oréal-UNESCO Australia & New Zealand For Women in Science Fellowship
2025 Bioactive Materials Best Paper Award
2023/20/21 Matrix Biology Society of Australia and New Zealand (MBSANZ) Paper of the Month Award (Jun 2023, Jan 2021, Oct 2020)
2019 Institute of Bone and Joint Research (IBJR) Basic Science Manuscript Award
2017 Rebecca L. Cooper Medical Research Foundation Medal
2016 Award of Excellence, University of Sydney
2011 Endeavour Research Fellowship, awarded by Australian Government to undertake research at Tufts University, USA
2010 6-Degrees of Freedom Award, Sydney Orthopaedic Research Institute (SORI) for the top Honours thesis in Biomedical Engineering
2010 University Medal, Bachelor of Engineering (Biomedical) / Bachelor of Medical Science, University of Sydney
2010-2021 20 conference best presentation awards, including at notable international (e.g., OARSI China Evening 2019; TERMIS-AP 2016) and national (e.g., AWTRS 2021, 2020; ASMR NSW 2020, 2018; ANZORS 2013) conferences; 16 travel grants to international and national conferencesCommittee roles for scientific/professional agencies and societies:
International:
- Tissue Engineering & Regenerative Medicine International Society (TERMIS) global Editorial Committee (2022–now)- TERMIS-AP Council Member (2026–now)
- Osteoarthritis Research Society International (OARSI) Communications Committee (2022–now) & Chair (2025–now), Early Career Investigator Committee (2019–2023), Diversity, Equity, Inclusion (DEI) Task Force (2022)
- Orthopaedic Research Society (ORS) Career Development Committee (2024–now)- ORS Ambassador for Australia (2026–now)
- International Federation of Musculoskeletal Research Societies (IFMRS), Future Global Leaders Committee (2024–now)National:
- Australian Research Council (ARC) Advisory Committee member (2025–now)
- Engineers Australia, Biomedical College Board & Biomedical College Sydney Branch Committee Chair (2026–now)
- Australian Academy of Technological Sciences & Engineering (ATSE), Emerging Leader/Health & Medical Technology Forum Member (2026–now)
- Science in Australia Gender Equity (SAGE), Lived Experience Advisory Panel (2026–now)
- Australian Institute of Policy and Science (AIPS), Board Director (2024–now)
- Science & Technology Australia, Board Director (2022–2025) & Equity, Diversity and Inclusion (EDI) Committee Chair (2023–2025)
- Australasian Society for Biomaterials and Tissue Engineering (ASBTE) Executive Committee (2025–now)
- Australian & New Zealand Bone and Mineral Society (ANZBMS) Early Career Investigator Committee (2020–2022), Communications Committee (2022–now)
- Australia & New Zealand Society for Extracellular Vesicles (ANZSEV), Executive Committee & Conference Co-Chair (2025)
- Australasian Wound & Tissue Repair Society (AWTRS) General Committee (2021–2024)
- Matrix Biology Society of Australia & New Zealand (MBSANZ) Executive Committee (2021–2024)
- Australian Academy of Science EMCR Forum Representative Network (2020–2021)
- Australian Society for Medical Research (ASMR) NSW Committee (2019–2020)Institution:
- UTS Representative, Global Challenge in Higher Education and Research (GHEAR) Steering Group, Worldwide Universities Network (WUN) (2022–2023)
- UTS Gender Equity Staff Ambassador (2020–now)
- Sydney Nano ECR Ambassador (2019–2021)
- Royal North Shore Hospital Scientific Staff Council Deputy Chair (2019) & Executive Committee (2018–2019)Editorial roles (selected):
- Editorial Board, Biomedical Materials (2026–now)
- International Editorial Board, Journal of Orthopaedic Translation (2026–now)
- Associate Editor, Cartilage (2024–now)
- Editorial Advisory Board, ACS Biomaterials Science & Engineering (2024–now)
- Young Investigator Council and Editorial Board of Tissue Engineering, Parts A, B, & C (2016–2019)- 3 Good Health and Well Being
- 4 Quality Education
- 5 Gender Equality
- Academic
- Masters Research or PhD student supervision
- Media enquiries
- Collaborative projects
- Industry Projects
- Membership of an advisory committee
Disciplines- Tissue engineering
- Regenerative medicine (incl. stem cells)
- Nanomedicine
- Rheumatology and arthritis
- Associate Professor
- Signal Processing and Analytics Discipline
- Associate ProfessorSignal Processing and Analytics Discipline
A/Prof. Steve Ling received his PhD in Electronic and Information Engineering from The Hong Kong Polytechnic University in 2007 and is currently an Associate Professor at the University of Technology Sydney (UTS). He is the Head of the AIVision Nexus Laboratory, leading research in artificial intelligence, medical imaging, and biomedical instrumentation.
A/Prof. Ling has published over 260 research papers, including more than 115 papers in leading international journals. His research focuses on developing innovative and trustworthy AI solutions for real-world healthcare and engineering applications. His pioneering work on non-invasive blood glucose monitoring using advanced AI techniques has been widely published in top biomedical journals and has contributed significantly to the field of digital health.
More recently, he has led several large-scale medical imaging projects involving ultrasound image analysis, automated image quality assessment, feature detection, and generative AI for clinical image enhancement and reconstruction. He is currently leading the development of next-generation Clinical Foundation Models for Echocardiography in collaboration with international clinical and industry partners. This research aims to leverage large-scale multimodal echocardiography data to develop foundation models capable of supporting automated image interpretation, quality assessment, clinical report generation, disease detection, and decision support. The project seeks to establish trustworthy and clinically deployable AI systems that can improve diagnostic accuracy, workflow efficiency, and accessibility of cardiac ultrasound services.
Through strong collaborations with international universities, hospitals, and industry partners, A/Prof. Ling has successfully secured more than 10 competitive research grants and industry-funded projects. He currently supervises over 10 PhD students and continues to drive translational AI research that bridges cutting-edge technology with real-world clinical and industrial impact.
Currently, he serves as Associate Editor for IET Electronics Letters , Sensors, IEEE Access, and CAAI Transactions on Intelligence Technology. Besides, He is active in international society. He has been a senior member of IEEE since 2012. In addition, He has been a reviewer of some international journals (e.g. IEEE Transactions), conferences and grant proposals. He also acted as session chair and organizer in several international conferences and workshops (such as NeurIPS). Since 2012, he served as Lead guest editor for many Q1 journals.In 2024, he awarded FEIT Early/Mid-Career Educator of the Year.
Since 2025, he was named among the World’s Top 2% Scientists by Stanford University.
A/Prof. Steve Ling received his PhD in Electronic and Information Engineering from The Hong Kong Polytechnic University in 2007 and is currently an Associate Professor at the University of Technology Sydney (UTS). He is the Head of the AIVision Nexus Laboratory, leading research in artificial intelligence, medical imaging, and biomedical instrumentation.
A/Prof. Ling has published over 260 research papers, including more than 115 papers in leading international journals. His research focuses on developing innovative and trustworthy AI solutions for real-world healthcare and engineering applications. His pioneering work on non-invasive blood glucose monitoring using advanced AI techniques has been widely published in top biomedical journals and has contributed significantly to the field of digital health.
More recently, he has led several large-scale medical imaging projects involving ultrasound image analysis, automated image quality assessment, feature detection, and generative AI for clinical image enhancement and reconstruction. He is currently leading the development of next-generation Clinical Foundation Models for Echocardiography in collaboration with international clinical and industry partners. This research aims to leverage large-scale multimodal echocardiography data to develop foundation models capable of supporting automated image interpretation, quality assessment, clinical report generation, disease detection, and decision support. The project seeks to establish trustworthy and clinically deployable AI systems that can improve diagnostic accuracy, workflow efficiency, and accessibility of cardiac ultrasound services.
Through strong collaborations with international universities, hospitals, and industry partners, A/Prof. Ling has successfully secured more than 10 competitive research grants and industry-funded projects. He currently supervises over 10 PhD students and continues to drive translational AI research that bridges cutting-edge technology with real-world clinical and industrial impact.
Currently, he serves as Associate Editor for IET Electronics Letters , Sensors, IEEE Access, and CAAI Transactions on Intelligence Technology. Besides, He is active in international society. He has been a senior member of IEEE since 2012. In addition, He has been a reviewer of some international journals (e.g. IEEE Transactions), conferences and grant proposals. He also acted as session chair and organizer in several international conferences and workshops (such as NeurIPS). Since 2012, he served as Lead guest editor for many Q1 journals.In 2024, he awarded FEIT Early/Mid-Career Educator of the Year.
Since 2025, he was named among the World’s Top 2% Scientists by Stanford University.
- Academic
- Masters Research or PhD student supervision
Disciplines- Artificial intelligence
- Biomedical engineering
- Biomedical imaging
- Adjunct Fellow
- Biomedical Engineering Discipline
- Adjunct FellowBiomedical Engineering Discipline
- Academic
- Graduate Research Student
- School of Biomedical Engineering
- Graduate Research StudentSchool of Biomedical Engineering
- Higher Degree by Research
- Distinguished Professor
- Biomedical Engineering Discipline
- Distinguished ProfessorBiomedical Engineering Discipline
Distinguished Professor Tuan V Nguyen AM is an internationally recognised researcher in osteoporosis, fracture prevention and predictive medicine. His research seeks to answer a deceptively simple but clinically important question: why do some individuals develop disease and adverse health outcomes while others do not — and how can that knowledge be used to predict and prevent those outcomes?
At UTS, Professor Nguyen is Distinguished Professor of Predictive Medicine, Director of the Centre for Health Technologies, and a Theme Lead in the UTS Ageing Research Collaborative. He is an NHMRC Leadership Fellow III and also holds an adjunct professorial appointment at UNSW Sydney. His research spans epidemiology, genetics, biostatistics, artificial intelligence and digital health, with a particular focus on translating population and genomic data into tools for personalised risk prediction and better healthcare decision-making.
Over more than three decades, his work has helped shift osteoporosis research from population-level associations towards individualised prediction of fracture, bone loss and post-fracture outcomes. He led the development of the Garvan Fracture Risk Calculator, which has been incorporated into major clinical guidelines internationally. Building on this work, his group developed BONEcheck™, a digital platform for personalised osteoporosis risk assessment, as well as the Osteogenomic Profile for integrating genomic information into fracture prediction and Skeletal Age, a novel approach to communicating an individual’s skeletal fragility.
A distinctive feature of his research is the integration of long-term population studies with emerging technologies. He has played a major role in the Dubbo Osteoporosis Epidemiology Study, one of the world's longest-running studies of osteoporosis and fracture, and leads the Vietnam Osteoporosis Study, a large population-based investigation of bone health and chronic disease in Vietnam. These resources provide a foundation for research combining clinical data, genomics, data science and AI to develop more precise approaches to disease prediction and prevention.
His current research extends beyond identifying individuals at high risk to a broader question of how risk can be reduced across entire populations. This includes the application of AI to clinical decision-making, digital epidemiology, risk communication, and new strategies for preventing hip fractures among people who may not meet conventional diagnostic thresholds for osteoporosis. This population-wide prevention approach has recently been a focus of his work at the UTS Ageing Research Collaborative.
Professor Nguyen's research has been published widely in leading medical and scientific journals, including The New England Journal of Medicine, The Lancet, JAMA, BMJ, Nature, Nature Genetics, and eLife. His research impact has achieved an h-index of 100 (Scopus 15/5/2025), and he has been recognised by ScholarGPS as a Highly Ranked Scholar (Lifetime), placing him among the top 0.05% of scholars worldwide for his lifetime scholarly contributions. He is an elected Fellow of the Australian Academy of Health and Medical Sciences, the Royal Society of New South Wales and the American Society for Bone and Mineral Research.
His contributions to osteoporosis research, prevention and higher education have been recognised through numerous awards and honours, including appointment as a Member of the Order of Australia (AM) in 2022, UTS Chancellor's Medal for Exceptional Research in 2018, UTS Medal for Research Impact in 2026, and the Lifetime Achievement Award from the Osteoporosis Society in Vietnam in 2026. In 2022, Professor Nguyen’s life and contributions to medical research, osteoporosis prevention and higher education were acknowledged in the Parliament of New South Wales by the Hon. Tania Mihailuk MP and the Hon. Wendy Lindsay MP.
Distinguished Professor Tuan V Nguyen AM is an internationally recognised researcher in osteoporosis, fracture prevention and predictive medicine. His research seeks to answer a deceptively simple but clinically important question: why do some individuals develop disease and adverse health outcomes while others do not — and how can that knowledge be used to predict and prevent those outcomes?
At UTS, Professor Nguyen is Distinguished Professor of Predictive Medicine, Director of the Centre for Health Technologies, and a Theme Lead in the UTS Ageing Research Collaborative. He is an NHMRC Leadership Fellow III and also holds an adjunct professorial appointment at UNSW Sydney. His research spans epidemiology, genetics, biostatistics, artificial intelligence and digital health, with a particular focus on translating population and genomic data into tools for personalised risk prediction and better healthcare decision-making.
Over more than three decades, his work has helped shift osteoporosis research from population-level associations towards individualised prediction of fracture, bone loss and post-fracture outcomes. He led the development of the Garvan Fracture Risk Calculator, which has been incorporated into major clinical guidelines internationally. Building on this work, his group developed BONEcheck™, a digital platform for personalised osteoporosis risk assessment, as well as the Osteogenomic Profile for integrating genomic information into fracture prediction and Skeletal Age, a novel approach to communicating an individual’s skeletal fragility.
A distinctive feature of his research is the integration of long-term population studies with emerging technologies. He has played a major role in the Dubbo Osteoporosis Epidemiology Study, one of the world's longest-running studies of osteoporosis and fracture, and leads the Vietnam Osteoporosis Study, a large population-based investigation of bone health and chronic disease in Vietnam. These resources provide a foundation for research combining clinical data, genomics, data science and AI to develop more precise approaches to disease prediction and prevention.
His current research extends beyond identifying individuals at high risk to a broader question of how risk can be reduced across entire populations. This includes the application of AI to clinical decision-making, digital epidemiology, risk communication, and new strategies for preventing hip fractures among people who may not meet conventional diagnostic thresholds for osteoporosis. This population-wide prevention approach has recently been a focus of his work at the UTS Ageing Research Collaborative.
Professor Nguyen's research has been published widely in leading medical and scientific journals, including The New England Journal of Medicine, The Lancet, JAMA, BMJ, Nature, Nature Genetics, and eLife. His research impact has achieved an h-index of 100 (Scopus 15/5/2025), and he has been recognised by ScholarGPS as a Highly Ranked Scholar (Lifetime), placing him among the top 0.05% of scholars worldwide for his lifetime scholarly contributions. He is an elected Fellow of the Australian Academy of Health and Medical Sciences, the Royal Society of New South Wales and the American Society for Bone and Mineral Research.
His contributions to osteoporosis research, prevention and higher education have been recognised through numerous awards and honours, including appointment as a Member of the Order of Australia (AM) in 2022, UTS Chancellor's Medal for Exceptional Research in 2018, UTS Medal for Research Impact in 2026, and the Lifetime Achievement Award from the Osteoporosis Society in Vietnam in 2026. In 2022, Professor Nguyen’s life and contributions to medical research, osteoporosis prevention and higher education were acknowledged in the Parliament of New South Wales by the Hon. Tania Mihailuk MP and the Hon. Wendy Lindsay MP.
- Academic
Disciplines- Health sciences
- Clinical sciences
- Biomedical engineering
- Head Of Discipline, SEDE Signal Processing And Analytics
- Signal Processing and Analytics Discipline
- Head Of Discipline, SEDE Signal Processing And AnalyticsSignal Processing and Analytics Discipline
Stuart Perry has over 25 years of experience conducting research into image processing, psychophysics, signal processing, image quality, and models for the quantification of image preference and aesthetics for both government, industry and academia. Following receiving a PhD from the University of Sydney in 1999, he began his research career studying the application of image processing to the detection of underwater objects in sector-scan sonar imagery for the Maritime Operations Division, Defence Science and Technology Organisation (DSTO). During this time he represented Australia on Computer-Aided Detection and Classification Specialist Group, Technical Panel 13 (Mine Warfare and High Frequency Acoustics), Maritime Group, The Technical Cooperation Program (TTCP).
From 2003 to 2016, he worked for Canon Information Systems Research Australia (CiSRA), a Canon group company and one of the Canon Group's largest R&D facilities outside of Japan. During this time he worked on camera white balancing technologies, and led research teams working on print quality measurement, document security and perceptual quality measurement for various consumer devices.
In 2016 he joined the FEIT's Perceptual Imaging Laboratory (PILab) as Co-Director conducting research into colour and perceptual quality in 3D environments. Stuart also represents PILab and UTS on a number of international standards committees such as ISO/TC 42 (Photographic standards), ISO/IEC/JTC 1/SC 29 (MPEG and JPEG) where he leads JPEG’s activity on point cloud coding standards and is the Chair of the Australian Mirror Committes for ISO/TC 42 and ISO/IEC/JTC 1/SC 29. He is also a member of SPINet and a Senior Member of IEEE. He is interested in point cloud and light field technologies, computer vision, 3D scanning and human perception in Virtual, Augmented and Mixed Reality environments. He is the author of over 70 professional and academic publications including 2 books and 20 patents and patent applications and is a senior editor of the SPIE/IS&T Journal of Electronic Imaging.Stuart Perry has over 25 years of experience conducting research into image processing, psychophysics, signal processing, image quality, and models for the quantification of image preference and aesthetics for both government, industry and academia. Following receiving a PhD from the University of Sydney in 1999, he began his research career studying the application of image processing to the detection of underwater objects in sector-scan sonar imagery for the Maritime Operations Division, Defence Science and Technology Organisation (DSTO). During this time he represented Australia on Computer-Aided Detection and Classification Specialist Group, Technical Panel 13 (Mine Warfare and High Frequency Acoustics), Maritime Group, The Technical Cooperation Program (TTCP).
From 2003 to 2016, he worked for Canon Information Systems Research Australia (CiSRA), a Canon group company and one of the Canon Group's largest R&D facilities outside of Japan. During this time he worked on camera white balancing technologies, and led research teams working on print quality measurement, document security and perceptual quality measurement for various consumer devices.
In 2016 he joined the FEIT's Perceptual Imaging Laboratory (PILab) as Co-Director conducting research into colour and perceptual quality in 3D environments. Stuart also represents PILab and UTS on a number of international standards committees such as ISO/TC 42 (Photographic standards), ISO/IEC/JTC 1/SC 29 (MPEG and JPEG) where he leads JPEG’s activity on point cloud coding standards and is the Chair of the Australian Mirror Committes for ISO/TC 42 and ISO/IEC/JTC 1/SC 29. He is also a member of SPINet and a Senior Member of IEEE. He is interested in point cloud and light field technologies, computer vision, 3D scanning and human perception in Virtual, Augmented and Mixed Reality environments. He is the author of over 70 professional and academic publications including 2 books and 20 patents and patent applications and is a senior editor of the SPIE/IS&T Journal of Electronic Imaging.- Academic
- Masters Research or PhD student supervision
- Industry Projects
- Membership of an advisory committee
- Collaborative projects
Disciplines- Computer vision and multimedia computation
- Lecturer
- Signal Processing and Analytics Discipline
- LecturerSignal Processing and Analytics Discipline
Thuy Pham earned her Ph.D degree in Electrical and Information Engineering at The University of Sydney, NSW, Australia. Her passion for signal processing started at The University of Arizona, USA with her MSc in Electrical and Computer Engineering in 2010, where she built her background on Neuroscience, Robotics, Digital Signal and Image Processing. She was awarded the UA Meritorious Awards (2010-2012) and the Research Grant, Neuroscience Dept., for her thesis on a real-time neural signal processing system for dragonflies towards hybrid bio-robots, at The Higgins Laboratory, Neuromorphic Vision and Robotic Systems, The University of Arizona. She received the Australian Prime Minister Award (Endeavour, 2013-2017) and Norman I. Price Scholarship for her PhD study.
Before joining UTS, she has been held visiting scholar appointments and collaborated with world-leading medical and physiology groups: The Fuglevand Laboratory on Motor Control Neurophysiology, USA;Brain and Mind Research Institute, Sydney Medical School; Woolcock Institute of Medical Research, NSW;Garvan Institute of Medical Research,Darlinghurst NSW Australia.Thuy Pham earned her Ph.D degree in Electrical and Information Engineering at The University of Sydney, NSW, Australia. Her passion for signal processing started at The University of Arizona, USA with her MSc in Electrical and Computer Engineering in 2010, where she built her background on Neuroscience, Robotics, Digital Signal and Image Processing. She was awarded the UA Meritorious Awards (2010-2012) and the Research Grant, Neuroscience Dept., for her thesis on a real-time neural signal processing system for dragonflies towards hybrid bio-robots, at The Higgins Laboratory, Neuromorphic Vision and Robotic Systems, The University of Arizona. She received the Australian Prime Minister Award (Endeavour, 2013-2017) and Norman I. Price Scholarship for her PhD study.
Before joining UTS, she has been held visiting scholar appointments and collaborated with world-leading medical and physiology groups: The Fuglevand Laboratory on Motor Control Neurophysiology, USA;Brain and Mind Research Institute, Sydney Medical School; Woolcock Institute of Medical Research, NSW;Garvan Institute of Medical Research,Darlinghurst NSW Australia.- Academic
- Masters Research or PhD student supervision
Disciplines- Biomedical engineering
- Professor
- Signal Processing and Analytics Discipline
- ProfessorSignal Processing and Analytics Discipline
Massimo Piccardi is a professor of natural language processing (NLP) and machine learning at the Faculty of Engineering and Information Technology, University of Technology Sydney (UTS), that he joined in 2002.
Over his career, Prof Piccardi has been the author or co-author of over two hundred scientific papers in international journals and conference proceedings and several book chapters. Since relocating to Australia from Italy in 2002, he has been the principal investigator of many advanced research projects including two ARC (Australian Research Council) Discovery Projects and an ARC Linkage Project, and a chief investigator in another Linkage Project and four Linkage Infrastructure Projects. Prof Piccardi has also received significant funding from several Cooperative Research Centres (CMCRC, FACRC, DHCRC).
Prof Piccardi serves as a member of the Editorial Board of the Artificial Intelligence In Medicine journal and has served as as an Associate Editor for several other journals in the past (IEEE Transactions on Big Data, CVIU, IVC, MVAP). He is a senior member of the IEEE, a member of its Computer and Systems, Man and Cybernetics Societies, a member of the International Association for Pattern Recognition, a member of the Association for Computational Linguistics, and has served as the 2023-2024 president of the Australasian Language Technology Association (ALTA). In 2022, Prof. Piccardi has been a recipient of the inaugural IEEE Computer Society Distinguished Contributor award.Massimo Piccardi is a professor of natural language processing (NLP) and machine learning at the Faculty of Engineering and Information Technology, University of Technology Sydney (UTS), that he joined in 2002.
Over his career, Prof Piccardi has been the author or co-author of over two hundred scientific papers in international journals and conference proceedings and several book chapters. Since relocating to Australia from Italy in 2002, he has been the principal investigator of many advanced research projects including two ARC (Australian Research Council) Discovery Projects and an ARC Linkage Project, and a chief investigator in another Linkage Project and four Linkage Infrastructure Projects. Prof Piccardi has also received significant funding from several Cooperative Research Centres (CMCRC, FACRC, DHCRC).
Prof Piccardi serves as a member of the Editorial Board of the Artificial Intelligence In Medicine journal and has served as as an Associate Editor for several other journals in the past (IEEE Transactions on Big Data, CVIU, IVC, MVAP). He is a senior member of the IEEE, a member of its Computer and Systems, Man and Cybernetics Societies, a member of the International Association for Pattern Recognition, a member of the Association for Computational Linguistics, and has served as the 2023-2024 president of the Australasian Language Technology Association (ALTA). In 2022, Prof. Piccardi has been a recipient of the inaugural IEEE Computer Society Distinguished Contributor award.- Academic
- Masters Research or PhD student supervision
Disciplines- Natural language processing
- Research Fellow
- Biomedical Engineering Discipline
- Research FellowBiomedical Engineering Discipline
I am an Early Career Scientist (ECR) at the School of Biomedical Engineering. I completed a Bachelor’s degree in Biochemistry and a Master’s degree in Biotechnology at the Autonomous University of Madrid (UAM), Spain. After completing my PhD in Molecular Biosciences (UAM), I moved to the Garvan Institute of Medical Research to pursue postdoctoral studies on breast cancer. (March 2019) During that period I gained technical and conceptual experience on the molecular mechanisms driving cancer chemotherapy resistance. I also developed a strong interest in the mechanisms of cell-cell communication in 3D models.
As an ECR I was awarded an international post-doctoral fellowship (Ramon Areces Foundation, 2020-2022). During that stage of my career, I also participated in successful grant applications, contributing to their design, writing and generation of preliminary data such as the Perpetual's IMPACT grant ($100K). I also supervised two honours students and a PhD student. Additionally, I was a member of the Postdoctoral Development Committee, an association that aims to complement the postdoctoral training, facilitating the acquisition of new skills through specialised seminars, cross-fertilising ideas organising workshops and symposiums with postdocs from 3 different MRIs and a Hospital.
In May 2022, I joined the School of Biomedical Engineering under the supervision of David Gallego-Ortega to work on using tissue-engineering platforms to understand tissue development and accelerate precision medicine in cancer with a strong focus on 3D models and confocal imaging.I am an Early Career Scientist (ECR) at the School of Biomedical Engineering. I completed a Bachelor’s degree in Biochemistry and a Master’s degree in Biotechnology at the Autonomous University of Madrid (UAM), Spain. After completing my PhD in Molecular Biosciences (UAM), I moved to the Garvan Institute of Medical Research to pursue postdoctoral studies on breast cancer. (March 2019) During that period I gained technical and conceptual experience on the molecular mechanisms driving cancer chemotherapy resistance. I also developed a strong interest in the mechanisms of cell-cell communication in 3D models.
As an ECR I was awarded an international post-doctoral fellowship (Ramon Areces Foundation, 2020-2022). During that stage of my career, I also participated in successful grant applications, contributing to their design, writing and generation of preliminary data such as the Perpetual's IMPACT grant ($100K). I also supervised two honours students and a PhD student. Additionally, I was a member of the Postdoctoral Development Committee, an association that aims to complement the postdoctoral training, facilitating the acquisition of new skills through specialised seminars, cross-fertilising ideas organising workshops and symposiums with postdocs from 3 different MRIs and a Hospital.
In May 2022, I joined the School of Biomedical Engineering under the supervision of David Gallego-Ortega to work on using tissue-engineering platforms to understand tissue development and accelerate precision medicine in cancer with a strong focus on 3D models and confocal imaging.- Academic
- Collaborative projects
- Masters Research or PhD student supervision
- Join a web conference as a panellist or speaker
- Membership of an advisory committee
Disciplines- Tissue engineering
- Cancer cell biology
- Molecular targets
- Molecular imaging (incl. electron microscopy and neutron diffraction)
- Image processing
- Genomics and transcriptomics
- Chancellor's Research Fellow
- Biomedical Engineering Discipline
- Chancellor's Research FellowBiomedical Engineering Discipline
Dr. Aaqil RIfai is a Chancellor's Research Fellow and an emerging biomaterials and tissue engineering academic. He has received over $900,000 in competitive research income. He currently co-supervises 3 PhD students from Deakin University. He is also an Honorary Research Associate at RMIT University.
In 2016, Dr. Rifai was invited to pursue a full-time PhD at RMIT University's School of Engineering under Prof. Kate Fox, Prof. Elena Pirogova, Dr. Nhiem Tran and Prof. Andrew Greentree. During his PhD, he developed the first diamond-coated additively manufactured titanium scaffolds for biomedical applications. These materials enhanced mammalian cell growth and inhibited Staphylococcus aureus colonisation. Dr. Rifai published over 10 high-quality peer-reviewed publications during his PhD. He created impact with his research, gaining media attention from over 30 media article reports, radio interviews (Triple RRR) and TV shows (Scope TV).
After completing his PhD in August 2020, Dr. Rifai secured a full-time postdoctoral research position at RMIT University. This position focused on developing novel lightweight materials for biomedical applications. Soon after, Dr. Rifai won the prestigious Alfred Deakin Postdoctoral Research Fellowship at Deakin University in March 2021, where he embarked on his independent research career. He developed novel self-assembled peptide hydrogels for bone tissue regeneration under the guidance of A/Prof. Richard Williams.
Dr. Rifai is currently developing organoid models mimicking the extracellular matrix with potential avenues for rapid, clinically relevant production of bone and cartilage tissue.Dr. Aaqil RIfai is a Chancellor's Research Fellow and an emerging biomaterials and tissue engineering academic. He has received over $900,000 in competitive research income. He currently co-supervises 3 PhD students from Deakin University. He is also an Honorary Research Associate at RMIT University.
In 2016, Dr. Rifai was invited to pursue a full-time PhD at RMIT University's School of Engineering under Prof. Kate Fox, Prof. Elena Pirogova, Dr. Nhiem Tran and Prof. Andrew Greentree. During his PhD, he developed the first diamond-coated additively manufactured titanium scaffolds for biomedical applications. These materials enhanced mammalian cell growth and inhibited Staphylococcus aureus colonisation. Dr. Rifai published over 10 high-quality peer-reviewed publications during his PhD. He created impact with his research, gaining media attention from over 30 media article reports, radio interviews (Triple RRR) and TV shows (Scope TV).
After completing his PhD in August 2020, Dr. Rifai secured a full-time postdoctoral research position at RMIT University. This position focused on developing novel lightweight materials for biomedical applications. Soon after, Dr. Rifai won the prestigious Alfred Deakin Postdoctoral Research Fellowship at Deakin University in March 2021, where he embarked on his independent research career. He developed novel self-assembled peptide hydrogels for bone tissue regeneration under the guidance of A/Prof. Richard Williams.
Dr. Rifai is currently developing organoid models mimicking the extracellular matrix with potential avenues for rapid, clinically relevant production of bone and cartilage tissue.- Academic
- Masters Research or PhD student supervision
- Associate Professor
- Biomedical Engineering Discipline
- Associate ProfessorBiomedical Engineering Discipline
Dr Roohani is an Associate Professor at the School of Biomedical Engineering, University of Technology Sydney (UTS), and an Adjunct Associate Professor in the School of Biomedical Engineering at the University of Sydney (USyd). His research focuses on the intersection of biology and materials science to explore fundamental biological questions and develop innovative biomaterials for a range of biomedical applications, including translational medicine. His work investigates how cells interact with surfaces and biological entities, particularly their responses to topographical and biochemical signals on various substrates. Dr Roohani's research is also directed towards translational programmes aimed at pioneering novel tissue engineering and 3D bioprinting strategies to regenerate damaged and diseased musculoskeletal tissues, and developing novel bioceramics. He has led advancements in bioceramics, polymeric biomaterials, and 3D printing technologies. Dr Roohani is the recipient of two prestigious fellowships: the National Health and Medical Research Council Early Career Fellowship and the Sydney Musculoskeletal Health Fellowship. He has authored more than 90 publications, with an h-index of 42. He has pioneered nanoscale printing of bone mimickes constructs and is also the inventor of a single-stage biofabrication technique, COBICS, which creates a 3D heterogeneous bone-analogous microenvironment, and Sr-HT-Gahnite, a bioceramic composition licensed by Allegra Orthopaedics. His work has secured over $2 million in funding and has led to translational outcomes, inventions, and numerous accolades, including being a finalist for the Eureka Prize for Innovative Use of Technology in 2023 and the Young Investigator Award of the Year in 2021 (TERMIS).
Available projects:
- Nanoscale 3D printing of ceramics and hydrogels
- Bone tissue on chips
- Biofabrication of bioinspired filamented tissues
- Biofabrication and bioprinting of functional tissues
- 3D printing of scaffolds with topological optimisation (lattice, curvature and microstructure)
- Next-generation bioceramics, bioactive glasses, and glass-ceramics
- Anti-senescent biomaterials
- Cell-modulating 3D nanointerfaces
- Damage-tolerant, lightweight materials
- Microgels and granular hydrogels
- Tough or injectable hydrogels for biomedical applications
- Artificial connective tissues and biofunctional membranes
- Antibacterial materials
- Multifunctional bone cements
Dr Roohani is an Associate Professor at the School of Biomedical Engineering, University of Technology Sydney (UTS), and an Adjunct Associate Professor in the School of Biomedical Engineering at the University of Sydney (USyd). His research focuses on the intersection of biology and materials science to explore fundamental biological questions and develop innovative biomaterials for a range of biomedical applications, including translational medicine. His work investigates how cells interact with surfaces and biological entities, particularly their responses to topographical and biochemical signals on various substrates. Dr Roohani's research is also directed towards translational programmes aimed at pioneering novel tissue engineering and 3D bioprinting strategies to regenerate damaged and diseased musculoskeletal tissues, and developing novel bioceramics. He has led advancements in bioceramics, polymeric biomaterials, and 3D printing technologies. Dr Roohani is the recipient of two prestigious fellowships: the National Health and Medical Research Council Early Career Fellowship and the Sydney Musculoskeletal Health Fellowship. He has authored more than 90 publications, with an h-index of 42. He has pioneered nanoscale printing of bone mimickes constructs and is also the inventor of a single-stage biofabrication technique, COBICS, which creates a 3D heterogeneous bone-analogous microenvironment, and Sr-HT-Gahnite, a bioceramic composition licensed by Allegra Orthopaedics. His work has secured over $2 million in funding and has led to translational outcomes, inventions, and numerous accolades, including being a finalist for the Eureka Prize for Innovative Use of Technology in 2023 and the Young Investigator Award of the Year in 2021 (TERMIS).
Available projects:
- Nanoscale 3D printing of ceramics and hydrogels
- Bone tissue on chips
- Biofabrication of bioinspired filamented tissues
- Biofabrication and bioprinting of functional tissues
- 3D printing of scaffolds with topological optimisation (lattice, curvature and microstructure)
- Next-generation bioceramics, bioactive glasses, and glass-ceramics
- Anti-senescent biomaterials
- Cell-modulating 3D nanointerfaces
- Damage-tolerant, lightweight materials
- Microgels and granular hydrogels
- Tough or injectable hydrogels for biomedical applications
- Artificial connective tissues and biofunctional membranes
- Antibacterial materials
- Multifunctional bone cements
- Academic
- Masters Research or PhD student supervision
- Career advice
- Collaborative projects
- Membership of an advisory committee
- Mentoring (long-term)
- Industry Projects
Disciplines- Tissue engineering
- Biomaterials
- Functional materials
- Additive manufacturing
- Biomedical engineering
- Lecturer
- Biomedical Engineering Discipline
- LecturerBiomedical Engineering Discipline
Dayna completed a Bachelors degree in Forensic Biology and biomedical science, followed by Honours in Medical and Molecular Biosciences. Dayna completed her PhD in HPV-induced Head and neck cancers at the University of Technology Sydney (UTS) under the supervision of Dr Nham Tran in 2022.
The primary focus of her PhD was to uncover the molecular mechanisms underlying HPV-induced cancers, specifically with a focus on microRNA and lncRNAs during cancer development.
After completing her PhD, she worked as a postdoctoral researcher with Dr Sheila Donnelly and Dr Nham Tran, working on cross-kingdom microRNAs during parasitic infections at the UTS. Specifically, she investigates the role microRNAs play during Helminth infections and how parasite transfers their own genetic material to regulate the host’s immune response.
Currently, Dayna’s research focuses on regulatory RNAs during infectious disease, specifically identifying potential novel diagnostics strategies.
In addition to research, Dayna has been committed to student learning and teaching various subjects in FEIT.
Dayna completed a Bachelors degree in Forensic Biology and biomedical science, followed by Honours in Medical and Molecular Biosciences. Dayna completed her PhD in HPV-induced Head and neck cancers at the University of Technology Sydney (UTS) under the supervision of Dr Nham Tran in 2022.
The primary focus of her PhD was to uncover the molecular mechanisms underlying HPV-induced cancers, specifically with a focus on microRNA and lncRNAs during cancer development.
After completing her PhD, she worked as a postdoctoral researcher with Dr Sheila Donnelly and Dr Nham Tran, working on cross-kingdom microRNAs during parasitic infections at the UTS. Specifically, she investigates the role microRNAs play during Helminth infections and how parasite transfers their own genetic material to regulate the host’s immune response.
Currently, Dayna’s research focuses on regulatory RNAs during infectious disease, specifically identifying potential novel diagnostics strategies.
In addition to research, Dayna has been committed to student learning and teaching various subjects in FEIT.
- Academic
- Collaborative projects
School contact
- +61 2 9514 2048